References
- Bloomer J R, et al. Dis Mon. 1989; 35(1)1–54
- Cram D L, Epstein J H, Tuffanelli D L. Lupus erythematosus and porphyria. Arch Dermatol. 1973; 108: 779–784
- Laux, et al. Simultaneous occurrence of lupus erythematosus and hepatic porphyria. Coincidence or chance association?. Z Hautkr. 1985; 21: 1714–1716
- Weatherhead L, et al. Discoid lupus erythematosus. Coexistence with porphyria cutanea tarda. Int J Dermatol. 1985; 24: 453–455
- Köstler E, et al. Occurrence of circulating autoantibodies in porphyria cutanea tarda. Dermatol Monatsschr. 1985; 171: 236–239
- Baravalle E, Prieto J. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease. Gastroenterol. 1983; 84: 1483–1491
- Elder G H, Smith S G, Herrero C, et al. Hepatoerythropoietic porphyria: A new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?. Lancet. 1981; 1: 916–919
- Bloomer J R, Straka J G. Porphyrin metabolism. The Liver Biology and Pathobiology, I M Arias, W B Jakoby, H Popper, et al. Raven Press, New York 1988; 451–466
- Verneuil H, Aitaken G, Nordmann Y. Familial and sporadic porphyria cutanea. Hum Genet. 1978; 44: 145–151
- Kushner J P. The enzymatic defect in porphyria cutanea tarda (editorial). N Engl J Med. 1982; 306: 799–800
- Deacon A C. Performance of screening tests for porphyria. Ann Clin Biochem. 1988; 25: 392–397
- Kushner J F, Steinmiller D P, Lee G R. The role of iron in the pathogenesis of porphyria cutanea tarda. Inhibition of uroporphyrinogen decarboxilase. J Clin Invest. 1975; 56: 661–664
- Kishner J P, Lee G R, Nacht S J. The role of iron in the pathogenesis of porphyria cutanea tarda. J Clin Invest. 1972; 51: 344–345
- Loveless M D, Straka J G, Bloomer J R. On the mechanism of liver damage in porphyria cutanea tarda. Hepatology. 1986; 6: 1160–1164